Literature DB >> 19010798

No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience.

David H Birnie1, Samuel F Sears, Martin S Green, Robert Lemery, Michael H Gollob, Barbara Amyotte.   

Abstract

AIMS: It is unclear whether there is important psychological morbidity associated with living with an implantable cardioverter defibrillator (ICD) under advisory and whether this should be factored into decision-making. METHODS AND
RESULTS: Our study focused on patients living with advisory Medtronic Marquis ICDs. Patient adjustment to the ICD was evaluated using a validated device-specific metric of patient acceptance, the Florida Patient Acceptance Survey (FPAS). A comparison group of patients with other models of ICDs that were not under an advisory also completed the study measure. The questionnaire return rate was 86/122 (70.5%) in the advisory group and 94/134 (70.1%) in the non-advisory group. Only one patient in our clinic elected for generator change due to severe anxiety. There were no differences in demographic or clinical variables between the groups. There were no differences in the mean total FPAS score between the two patient groups (advisory patients 85.97 +/- 14.95 and 86.23 +/- 15.76 for non-advisory, P=0.340). Also there were no differences in any of the subscores. Correlates of poor device acceptance were younger age and a history of electrical storm.
CONCLUSION: We found no evidence of increased long-term psychological morbidity in patients living with an ICD under advisory compared with patients with an ICD not under advisory. Our data suggest that patients and physicians should avoid hasty decisions about ICD replacement for psychological reasons.

Entities:  

Mesh:

Year:  2008        PMID: 19010798     DOI: 10.1093/europace/eun317

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  The effect of device advisories on implantable cardioverter-defibrillator therapy.

Authors:  Mitesh S Amin; Kenneth A Ellenbogen
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 2.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

3.  Perspectives of patients with cardiovascular implantable electronic devices who received advisory warnings.

Authors:  Abigale L Ottenberg; Luke A Mueller; Paul S Mueller
Journal:  Heart Lung       Date:  2013 Jan-Feb       Impact factor: 2.210

4.  Relationship between device acceptance and patient-reported outcomes in Left Ventricular Assist Device (LVAD) recipients.

Authors:  Crispino Tosto; Luigi Adamo; Heidi Craddock; Maria Di Blasi; Rosario Girgenti; Francesco Clemenza; Robert M Carney; Gregory Ewald
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.